| Dr Michelle Quinn, AUD | |
|
325 9th Ave, Hmc - Audiology, Seattle, WA 98104-2420 | |
| (206) 372-5549 | |
| Not Available |
| Full Name | Dr Michelle Quinn |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 325 9th Ave, Seattle, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073882379 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | LD 60246167 (Washington) | Primary |
| Provider Name | University Of Washington |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326002049 PECOS PAC ID: 3274445150 Enrollment ID: O20040105000544 |
News Archive
By using a chemical analysis method developed for air-pollution testing, UCI chemists and pediatricians have found that people with cystic fibrosis exhale higher concentrations of sulfur compounds from their lungs than do people who don't have the disease.
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Nippon Gene Co., Ltd (Nippon Gene), a manufacturer of genetic engineering research reagents and diagnostic reagents for humans, animals, and plants, today announced a non-exclusive license agreement granting Nippon Gene access to ERS Genomics' CRISPR/Cas9 patent portfolio.
Is the emerging field of nanomedicine a breathtaking technological revolution that promises remarkable new ways of diagnosing and treating diseases? Or does it portend the release of dangerous nanoparticles, nanorobots or nanoelectronic devices that will wreak havoc in the body? A new review of more than 500 studies on the topic concludes that neither scenario is likely. It appears in ACS' journal Molecular Pharmaceutics.
There is general agreement among hospital infection preventionists (IPs) with respect to which practices have weak or strong evidence supporting their use to prevent healthcare-associated infection, according to a new study published in the February issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 3 days ago
| Provider Name | Harborview Medical Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1568557312 PECOS PAC ID: 3971404716 Enrollment ID: O20040115000760 |
News Archive
By using a chemical analysis method developed for air-pollution testing, UCI chemists and pediatricians have found that people with cystic fibrosis exhale higher concentrations of sulfur compounds from their lungs than do people who don't have the disease.
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Nippon Gene Co., Ltd (Nippon Gene), a manufacturer of genetic engineering research reagents and diagnostic reagents for humans, animals, and plants, today announced a non-exclusive license agreement granting Nippon Gene access to ERS Genomics' CRISPR/Cas9 patent portfolio.
Is the emerging field of nanomedicine a breathtaking technological revolution that promises remarkable new ways of diagnosing and treating diseases? Or does it portend the release of dangerous nanoparticles, nanorobots or nanoelectronic devices that will wreak havoc in the body? A new review of more than 500 studies on the topic concludes that neither scenario is likely. It appears in ACS' journal Molecular Pharmaceutics.
There is general agreement among hospital infection preventionists (IPs) with respect to which practices have weak or strong evidence supporting their use to prevent healthcare-associated infection, according to a new study published in the February issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Quinn, AUD 325 9th Ave, Hmc - Audiology, Seattle, WA 98104-2420 Ph: (206) 372-5549 | Dr Michelle Quinn, AUD 325 9th Ave, Hmc - Audiology, Seattle, WA 98104-2420 Ph: (206) 372-5549 |
News Archive
By using a chemical analysis method developed for air-pollution testing, UCI chemists and pediatricians have found that people with cystic fibrosis exhale higher concentrations of sulfur compounds from their lungs than do people who don't have the disease.
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Nippon Gene Co., Ltd (Nippon Gene), a manufacturer of genetic engineering research reagents and diagnostic reagents for humans, animals, and plants, today announced a non-exclusive license agreement granting Nippon Gene access to ERS Genomics' CRISPR/Cas9 patent portfolio.
Is the emerging field of nanomedicine a breathtaking technological revolution that promises remarkable new ways of diagnosing and treating diseases? Or does it portend the release of dangerous nanoparticles, nanorobots or nanoelectronic devices that will wreak havoc in the body? A new review of more than 500 studies on the topic concludes that neither scenario is likely. It appears in ACS' journal Molecular Pharmaceutics.
There is general agreement among hospital infection preventionists (IPs) with respect to which practices have weak or strong evidence supporting their use to prevent healthcare-associated infection, according to a new study published in the February issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 3 days ago
Denise Suzanne Welch, L.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1600 E John St, Seattle, WA 98112 Phone: 425-330-3440 | |
Debra Sue Johnson, MA Audiologist Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St, Box 356515, Seattle, WA 98195 Phone: 206-543-5230 | |
Dr. Pamela E Souza, PHD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1660 S Columbian Way, Seattle, WA 98108 Phone: 206-764-2404 | |
Uw Speech & Hearing Clinic Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4131 15th Ave. Ne, Seattle, WA 98105 Phone: 206-543-5440 Fax: 206-616-1185 | |
Ms. Sami Alexandra O'neill, M.A. CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1660 S Columbian Way, Audio-126, Seattle, WA 98108 Phone: 206-764-2499 Fax: 206-764-2672 | |
Laura K Comer, MS Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-223-6600 | |
Jody Beth Smith, AU.D. CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-625-7373 Fax: 206-223-2388 |